Bioceres stabilizes Q4 performance with positive adjusted EBITDA following an 18% annual revenue drop, as management shifts focus to core profitability and debt reprofiling.
Bioceres reported an 18% revenue decline for FY2026, but Q4 showed stabilization with positive adjusted EBITDA driven by cost cuts.
Bioceres Crop Solutions posted an 18% revenue decline for fiscal year 2026, totaling $238 million, as the company navigated a major seed business reconfiguration and ongoing creditor litigation. Despite the top-line pressure, the firm achieved a return to positive adjusted EBITDA in the fourth quarter, driven by aggressive cost-cutting measures and a 19% reduction in SG&A expenses.
The 18% revenue decline was primarily driven by the reconfiguration of the company's seed business strategy and lower performance in the international crop protection segment.